FindTrial
Sign In

Distribution of anti-NMDA receptors and immunoglobulin G in teratomas with anti-NMDAR encephalitis

Expression of NMDA receptor in teratoma associated with anti-NMDA receptor encephalitis and its correlation with clinical characteristics

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900027074
Enrollment
Unknown
Registered
2019-10-30
Start date
2019-11-02
Completion date
Unknown
Last updated
2019-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Encephalitis

Interventions

NMDAE-teratoma group :Immunohistochemistry
common teratoma group:Immunohistochemistry

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. acute or subacute onset, associated neuropsychiatric symptoms, positive anti-NMDAR antibody in cerebrospinal fluid or serum, meeting the diagnostic criteria for anti-NMDAR encephalitis; 2. if the patient has a complicated teratoma, the teratoma should be removed in west China hospital and the postoperative specimens should be well preserved 3. complete clinical data, and the patient and his/her family members can cooperate to complete relevant examinations and follow-up.

Exclusion criteria

Exclusion criteria: Other diagnosis of encephalitis cannot be excluded.

Design outcomes

Primary

MeasureTime frame
NR1;NR2A;NR2B;IgG;—

Countries

China

Contacts

Public ContactJinmei Li

West China Hospital of Sichuan University

jxy7758@163.com+86 18990010716

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 26, 2026